Guillermo Garcia-Manero, Uwe Platzbecker, Pierre Fenaux, Gail Roboz, Chun Yew Fong, Marek Hus, Robert Delage, Andrew Brunner, Je-Hwan Lee, Mehmet Turgut, Dominiek Mazure, Yin-Hsun Feng, Yasushi Miyazaki, Zdeněk Kořístek, Sophie Salazar, Stefania Paolini, Maria Diez-Campelo, David Lavie, Dominic Culligan, Grace Ku, Zhijian Xiao, Fang Fang, Maggie Headley, Jalaja Potluri, Amer Zeidan, Jacqueline Garcia. "Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)." Blood, 2025. doi:10.1182/blood-2025-235